Related references
Note: Only part of the references are listed.Urinary transferrin pre-emptively identifies the risk of renal damage posed by subclinical tubular alterations
Alfredo G. Casanova et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Impaired Tubular Reabsorption Is the Main Mechanism Explaining Increases in Urinary NGAL Excretion Following Acute Kidney Injury in Rats
Sandra M. Sancho-Martinez et al.
TOXICOLOGICAL SCIENCES (2020)
Combined use of GM2AP and TCP1-eta urinary levels predicts recovery from intrinsic acute kidney injury
Victor Blanco-Gozalo et al.
SCIENTIFIC REPORTS (2020)
Postreperfusion plasma endothelial activation markers are associated with acute kidney injury after lung transplantation
Caitlin M. Forker et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
IL-6-mediated hepatocyte production is the primary source of plasma and urine neutrophil gelatinase associated lipocalin during acute kidney injury
Nataliya I. Skrypnyk et al.
KIDNEY INTERNATIONAL (2019)
Plasminogen Activator Inhibitor Type-1 as a Regulator of Fibrosis
Reyhaneh Rabieian et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Mechanisms Underlying Increased TIMP2 and IGFBP7 Urinary Excretion in Experimental AKI
Ali C. M. Johnson et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Phenotyping of Acute Kidney Injury: Beyond Serum Creatinine
Dennis G. Moledina et al.
SEMINARS IN NEPHROLOGY (2018)
Cell-cycle arrest and acute kidney injury: the light and the dark sides
John A. Kellum et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2016)
Novel Plasminogen Activator Inhibitor-1 Inhibitors Prevent Diabetic Kidney Injury in a Mouse Model
Bo Yeong Jeong et al.
PLOS ONE (2016)
Targeting Inflammation in So-Called Acute Kidney Injury
Shrikant R. Mulay et al.
SEMINARS IN NEPHROLOGY (2016)
A discrete cluster of urinary biomarkers discriminates between active systemic lupus erythematosus patients with and without glomerulonephritis
Carolina Landolt-Marticorena et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Adipose Tissue-Derived Plasminogen Activator Inhibitor-1 Function and Regulation
Hiroshi Kaji
COMPREHENSIVE PHYSIOLOGY (2016)
Acute kidney injury: from clinical to molecular diagnosis
Claudio Ronco
CRITICAL CARE (2016)
The definition of acute kidney injury and its use in practice
Mark E. Thomas et al.
KIDNEY INTERNATIONAL (2015)
Cell cycle arrest and the evolution of chronic kidney disease from acute kidney injury
Guillaume Canaud et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Abrogation of Plasminogen Activator Inhibitor-1-Vitronectin Interaction Ameliorates Acute Kidney Injury in Murine Endotoxemia
Kamlesh K. Gupta et al.
PLOS ONE (2015)
The link between acute kidney injury and chronic kidney disease
Linda Y. Belayev et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2014)
Therapeutic translation in acute kidney injury: the epithelial/endothelial axis
Bruce A. Molitoris
JOURNAL OF CLINICAL INVESTIGATION (2014)
Functional Stability of Plasminogen Activator Inhibitor-1
Songul Yasar Yildiz et al.
TheScientificWorldJOURNAL (2014)
Clinical value of inflammatory urinary biomarkers in overt diabetic nephropathy: A prospective study
Jacobien C. Verhave et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2013)
Cardiotrophin-1 Administration Prevents the Renal Toxicity of Iodinated Contrast Media in Rats
Yaremi Quiros et al.
TOXICOLOGICAL SCIENCES (2013)
PAI-1, progress in understanding the clinical problem and its aetiology
Takayuki Iwaki et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
PAI-1 in tissue fibrosis
Asish K. Ghosh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Subclinical AKI is still AKI
Claudio Ronco et al.
CRITICAL CARE (2012)
Pathophysiology of Acute Kidney Injury
David P. Basile et al.
COMPREHENSIVE PHYSIOLOGY (2012)
Adipokines and thrombosis
Katrin Schaefer et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2011)
An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity
Penelope D. Sanchez-Gonzalez et al.
CRITICAL REVIEWS IN TOXICOLOGY (2011)
Pathophysiology of ischemic acute kidney injury
Asif A. Sharfuddin et al.
NATURE REVIEWS NEPHROLOGY (2011)
Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rate
Sushrut S. Waikar et al.
KIDNEY INTERNATIONAL (2010)
Sub-nephrotoxic doses of gentamicin predispose animals to developing acute kidney injury and to excrete ganglioside M2 activator protein
Yaremi Quiros et al.
KIDNEY INTERNATIONAL (2010)
Positive Feedback Loop between Plasminogen Activator Inhibitor-1 and Transforming Growth Factor-Beta1 during Renal Fibrosis in Diabetes
Ji Yeon Seo et al.
AMERICAN JOURNAL OF NEPHROLOGY (2009)
PAI-1 and kidney fibrosis
Li-Jun Ma et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Connecting the dots: obesity, fatty acids and cancer
Philip A. Wood
LABORATORY INVESTIGATION (2009)
The role of plasminogen activator inhibitor 1 in renal and cardiovascular diseases
Hunjoo Ha et al.
NATURE REVIEWS NEPHROLOGY (2009)
PAI-1 as a target in kidney disease
Yufeng Huang et al.
CURRENT DRUG TARGETS (2007)
Update on mechanisms of ischemic acute kidney injury
Prasad Devarajan
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
The role of plasminogen activator inhibitor type 1 in the inflammatory response to local tissue injury
R Renckens et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Endothelial injury and dysfunction: Role in the extension phase of acute renal failure
BA Molitoris et al.
KIDNEY INTERNATIONAL (2004)
Ischemia-reperfusion induces glomerular and tubular and activation of proinflammatory and antiapoptotic pathways: Differential modulation by rapamycin
A Loverre et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Plasminogen activator inhibitor-1 and the kidney
AA Eddy
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2002)
Platelet, but not endothelial, P-selectin is critical for neutrophil-mediated acute postischemic renal failure
K Singbartl et al.
FASEB JOURNAL (2001)